Skip to Content

Alector Inc

Rating as of

Company Profile

Business Description

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

131 Oyster Point Boulevard, Suite 600
South San Francisco, CA, 94080
T +1 415 231-5660
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Speculative Growth
Employees 126